Global X Information Technology Covered Call Growth ETF (TYLG) Options

BITCOIN BCH $140,000 FEBRUARY TARGET Pink Floyd - MONEY

UNCY is supposed to have a commercialization plan presented this Qt .
The Co needs to ramp up but and be ready to roll as soon as OLC is approved . The time line for the TDAPA process ...which is CMS payments beginning is at best 3 mths from approval .
Some recent examples
For

could be spoon bending time...go... $AABB

I'm having a few drinks tonight listening to the devils violinist, I am retired thanks to plays like $PSRU!

https://www.youtube.com/watch?v=vihq22xpl1A

$60.00 as of the last filing...

I don't know. You're the f@cking expert. You've devoted your entire pathetic life to this shit.

I'm not even trying to be funny when I say this but the other day I saw a crow eating garbage in a parking lot and I literally thought of you.

RDAR

XRP ETF no more lawsuit ✊😎☝️ WOOHOOOOOO next level up 🪙🪙Hotel California

Meaningless since a true supply/demand dynamic isn't operating.

The real upside lies in RSV and Enanta’s shift toward becoming an immunology-focused company. Mavyret remains a factor, but the real potential comes from these strategic moves. If executed well, this could be a great setup—we’ll see how it unfolds in the next few quarters.

The waiting

I’m not sure why, but I can’t believe you are still a believer. Now, more than ever, you have to admit I was right all along. Or couldn’t you care less?

Since our patience is starting to grow weary, I figured I would remind everyone of the last 10Q's highlights and what's in store here soon:

Overview

During the first nine months of 2024, the Company continued its progress on multiple fronts, including the following.

$13 volume

CRISPR platforms can result in off-target modifications, unwanted on-target modifications, and genomic rearrangements.

Kim switched to a non-crispr knock in/knock out method. The knock-in knock-out technology allows KBL to work with more complex protein sequences, which are about four

RITE (Mineral Rite)

https://mineral-rite.com/investor-relations/

https://www.otcmarkets.com/stock/RITE/disclosure

https://x.com/mineralrite/status/1884771921897853390?s=46


read up on this one. if things go as some say, RITE will be

SMCI has the 33.06 gap down from Friday

01/24 that could fill quick in a price

upturn...44.09 next gap down area...

Around 32.5 was the simple moving price

average when gap down happened...

It happened with 2 selling days, Th

Share reductions forthcoming!

https://investorshub.advfn.com/uimage/uploads/2017/5/1/fxbnpMoving-picture-money-stacking-up-gif-animation.gif

Despite showing essentially no effectiveness in a Phase 2 study for LSR - Suzetrigine showed a mean reduction of 2.02 points on the NPRS at week 12, compared to a 1.98 point reduction in the placebo group - the FDA just approved it. Go Figure!

The near-identical reduction to placebo

I too ...but i have been buying down here to try and recoup a little.
Seems to be going up.

Bro,

I repeatedly mentioned about why it cannot be mRNA and listed all the reasons. In terms of immunotherapy, who has better judgement? Larry Ellison or Baker Brothers?

Now read this again. I am only allowed one post a day and I want to save my one post to some fake l

positive momentum will keep building up till earnings day, we will be flying to the moon.
0.90$ in 2 weeks

I believe Ben will take care of the shareholders. JMHO 

GO $MCIC 

This guy gets it!
This had to be brought back to life after a hissy fit removal too? Comedy.
Geeeeeeeez what a wah wah.

Elituv is owed over 1.2 million dollars minimum. Still waiting to see what compensation he gets for giving up control too. 6.5B is alot left to dilut

***MAJOR BREAKOUT *** mentions MOBILE #1 On Top5 crypto to $1 from here!
Kabooooom!!!!

What's your next prediction? Maybe that the MAA application will never be submitted? How'd that work out for you?

Are you and Mikey the Disgruntled Golfer having lunch at Yips by Hanover Square? Your sponsor won't even take you there? 😂 You boys should unionize.